Upregulation of the Vascular Alpha-1 Receptor in Malignant Doca-salt Hypertension

References

• Seyle H, Hall C E, Rowley E M. Malignant hypertension produced with deoxycorticosterone acetate and sodium chloride. Can. Med. Assoc. Jour. 1943; 49: 88–92
   PubMedGoogle Scholar
• Theil G, Huguenin M, Torhorst J, Peters L, Peters G, Brunner H. Low renin and high renin hypertension in the rat. Correlation between blood pressure, plasma renin activities and severity of vascular damage. Kid. Inter. 1973; 3: 273A
   Web of Science ®Google Scholar
• Reid J L, Zivin J A, Kopin I J. Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone - saline hypertension in rats. Circ. Res. 1975; 37: 569–579
   PubMed Web of Science ®Google Scholar
• Katholi R E, Naftilan A J J., Oparil S. Importance of renal sympathetic tone in the development of doca-salt hypertension. Hyper. 1980; 2: 266–273
   PubMed Web of Science ®Google Scholar
• Haeusler G, Finch L, Thoenen H. Central adrenergic neurons and the initiation and development of experimental hypertension. Experien. 1972; 28: 1200–1203
   PubMedGoogle Scholar
• DeChamplain J, Meuller R A, Axelrod J. Turnover and synthesis of norepinephrine in experimental hypertension. Circ. Res. 1969; 25: 285–291
   PubMed Web of Science ®Google Scholar
• Bellin L J, Wade D N, Honour A J, Cole T J. Vascular hyperreactivity with sodium loading and with deoxycorticosterone induced hypertension in the rat. Clin. Sci. 1970; 39: 793–810
   PubMedGoogle Scholar
• Morel R S, Webb R C, Bohr D I. Vascular changes in DOCA hypertension; influence of a low protein diet. Hyper. 1982; 4: 111–99; 111–107
   Google Scholar
• Meggs L G, Katzberg R W, DeLeeuw P, Hollenberg N K. Specific desensitization of the canine renal vasculature to angiotensin II despite cyclooxygenase inhibition. Yale Jour. Biol. and Med. 1985; 58: 453–458
   PubMed Web of Science ®Google Scholar
• Feldman R D, Limbird L E, Nadeau J, Fitzgerald G A, Robertson D, Wood A J. Dynamic Regulation of leukocyte beta adrenergic receptor - agonist interactions by physiological changes in circulating catecholamines. Jour. Clin. Invest. 1983; 72: 164–170
   PubMed Web of Science ®Google Scholar
• Yamada S, Yamamura H I, Roeske W R. Alterations in central and peripheral adrenergic receptors in deoxycorticosterone salt hypertensive rats. Life Sci. 1980; 27: 2405–2416
   PubMed Web of Science ®Google Scholar
• Gavras H, Brunner H R, Laragh J H, Vaughan E D, Koss M, Cote L, Gavras I. Malignant hypertension resulting from deoxycorticosterone acetate and salt excess. Circ. Res. 1975; 36: 300–309
   PubMed Web of Science ®Google Scholar
• Mohring B, Petri M, Haack D. Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension. Am. Jour. Phys. 1977; 232: F260–269
   PubMed Web of Science ®Google Scholar
• Colucci N S, Gimbone M A, Alexander R W. Regulation of the postsynaptic alpha adrenergic receptor in rat mesenteric artery. Effects of chemical sympathectomy and epinephrine treatment. Circ. Res. 1981; 48: 104–112
   PubMed Web of Science ®Google Scholar
• Adams A, Jarrot B. Development of a radioiodinated ligand for characterizing alpha-1 adrenoceptors. Life Sci 1982; 30: 945–952
   PubMed Web of Science ®Google Scholar
• Steinberg S F, Bilezikian J P. Identification and characterization of alpha-1 adrenergic receptors in rat myocardium wiht a new iodinated radioligand [125I] IBE 2254. Jour. of Mol. and Cell. Cardiol. 1982; 14: 601–610
   PubMed Web of Science ®Google Scholar
• Stiles G L, Hoffman B B, Hubbard M, Caron M G, Lefkowitz R J. Guanine nucleotides and alpha-1 adrenergic receptors in the heart. Biochem. Pharmacol. 1983; 32: 69–71
   PubMed Web of Science ®Google Scholar
• Pfeffer J M, Pfeffer M A, Frolich E D. Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthesized normotensive and hypertensive rats. Jour. Clin. Med. 1971; 78: 957–962
   PubMed Web of Science ®Google Scholar
• Lowry O H, Rosenbrough N J, Farr A L, Randall R J. Protein measurement with the Folin phenol reagent. Jour. Bio. Chem. 1951; 193: 265–270
   PubMed Web of Science ®Google Scholar
• Meggs L G, Ben-Ari J, Gammon D, Choudhury M, Goodman A I. Effect of chronic uremia on the cardiovascular alpha-1 receptor. Life Sci 1986; 39: 169–179
   PubMed Web of Science ®Google Scholar
• Longhurst P A, Head R J. Responses of the isolatedperfused mesenteric vasculature from diabetic rats: The appropriate control tissues. Jour. Pharm. Exp. Ther. 1985; 235: 45–49
   PubMed Web of Science ®Google Scholar
• Scatchard G. The attractions of proteins for small molecules and ions. Ann. NY Acad, Sci. 1949; 51: 600–672
   Web of Science ®Google Scholar
• Insel P A. Identification and regulation of adrenergic receptors in target cells. Amer. Jour. Phys. 1984; 247: E53–E58
   PubMed Web of Science ®Google Scholar
• Berkowitz B A, Tarver J H, Spector S. Norepinephrine in blood vessels: Concentration, binding uptake and depletion. Jour. Pharm. Exp. Ther. 1971; 177: 199–135
   Google Scholar
• Head R J, Hempstead J, Berkowitz B A. Catecholamines in the vasculature of the rat and rabbit: dopamine, norepinephrine, epinephrine. Blood Vess 1982; 19: 135–147
   PubMedGoogle Scholar
• Bevan J A. Some basis of differences in vasculature in vascular response to sympathetic activity. Circ. Res. 1979; 45: 161–171
   PubMed Web of Science ®Google Scholar
• Bristow M R. The adrenergic nervous system in heart failure. New Eng. Jour. Med. 1984; 311: 850–851
   PubMed Web of Science ®Google Scholar
• Colucci W S, Gimbone M A, Alexander R W. Regulation of myocardial and vascular alpha adrenergic receptor affinity: Effects of guanine nucleotides, cations, estrogen and catecholamine depletion. Circ. Res. 1984; 58: 78–88
   Google Scholar
• Crabb G A, Head R J, Hempstead J, Berkowitz B A. Altered disposition of catecholamines in hypertensive (Doca-Salt) rats. Clin. and Exper. Hyper. 1980; 2(1)129–138
   PubMed Web of Science ®Google Scholar
• DeChamplain J, Krakoff L R, Axelrod J. Relationship between sodium intake and norepinephrine storage during the development of experimental hypertension. Circ. Res. 1968; 23: 479–491
   Web of Science ®Google Scholar
• Katovich M J, Soltis E E, Iloeje E, Field F D. Time course alterations in vascular adrenergic responsiveness in the DOCA/NaCl treated rat. Pharm. 1984; 29: 173–180
   PubMed Web of Science ®Google Scholar
• Vatner D E, Homey C J, Sit S P, Manders W T, Vatner S F. Effects of pressure overload, left ventricular hypertrophy on B-adrenergic receptors, and responsiveness to catecholamines. J. Clin. Invest 1984; 73: 1473–1482
   PubMed Web of Science ®Google Scholar
• Vanbrummelen P, Vermey P, Timmermans W M, Vanweiten P LA. Preliminary evidence for a postsynaptic alpha2 receptor in the vasculature of the human forearm. Br. Jour. Clin. Pharm. 1983; 15: 134–135
   Google Scholar
• Drew G M, Whitting S B. Evidence for two distinct types of postsynaptic alpha adrenoceptor in vascular smooth muscle in vivo. Br. Jour. Pharm. 1979; 67: 207–215
   PubMed Web of Science ®Google Scholar
• Elliot H L, Jones C R, Vincent J, Reid J L. Alpha adrenoreceptor antagonist action of RX781094 in man: selective effects on alpha2 adrenoreceptors. Br. Jour. Clin. Pharm. 1983; 15: 598
   Google Scholar
• Ablaster V, Davy M J. Precapillary vessels: Effects of the sympathetic nervous system and of catecholamines. Jour. Cardiovas. Pharm. 1984; S(2)53–65
   Google Scholar
• DeChamplain J, Farley L, Cousineau D, Van Amerigen M R. Circulating catecholamine levels in human and experimental hypertension. Cir. Res. 1976; 38: 109–114
   PubMed Web of Science ®Google Scholar
• Friedman S M, Nakashima S M. Evidence for enhanced sodium transport in hypertension induced by DOCA in the rat. Can. J. Physiol. Pharmacol. 1978; 56: 1029–1035
   PubMed Web of Science ®Google Scholar
• Brock T A, Smith J B, Overbeck H W. Relationship of Vascular Sodium Potassium Pump Activity to Intracellular Sodium in Hypertensive Rats. Hyper 1982; 1143–1151, (11) 4: No. 3
   Google Scholar